GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia
SHANGHAI, Jan. 11, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company developing…